Physician profile
Michael C Kilpatrick
NPI 1083678304
$624.09
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $50.54 · 2021: $33.99 · 2022: $77.48 · 2023: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $70.54 | 2019-2023 | Wegovy |
| Pfizer INC. | $59.15 | 2019-2020 | |
| Amgen INC. | $54.88 | 2019 | |
| Novartis Pharmaceuticals Corporation | $53.74 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.40 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $42.67 | 2019 | |
| Abbvie INC. | $36.69 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $32.22 | 2023 | Quviviq |
| Astellas Pharma US INC | $30.30 | 2019 | |
| Glaxosmithkline, LLC. | $28.15 | 2019-2023 | Shingrix |
| Gilead Sciences, INC. | $23.64 | 2023 | |
| Lilly USA, LLC | $22.99 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $16.12 | 2022 | |
| Exact Sciences Corporation | $15.97 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $15.22 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $13.82 | 2019 | |
| Allergan, INC. | $12.06 | 2019 | |
| Amarin Pharma, INC. | $11.82 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $11.77 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.11 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kilpatrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.